Subtle signs of neurodegeneration can be detected in blood, CSF, and neuroimaging, up to 20 years before the motor symptoms ...

The oversubscribed Series B will boost the clinical development of two RNAi therapies for epilepsy and Huntington’s disease ...

Teva Pharmaceutical Industries reported a slightly larger than expected rise in fourth-quarter profit, helped by double-digit ...

THE MOTHER of a Wrexham man who has died following a long battle with illness has hailed him as an 'inspiration'. Christopher Bennett, from Llay, passed away aged 43 years old on January 8, surrounded ...

H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on QURE stock, giving a Buy rating on January 21.Invest with ...

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat ...

This study presents a valuable finding on the alterations in the autophagic-lysosomal pathway in a Huntington's disease model. The evidence supporting the claims of the authors is solid. However, the ...

Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the completion of a $97 million Series B financing to ...

Carol Lynn Balkus, nee Carol Lynn Fry, who passed away January 15, 2025, at her home in Rio Rancho, New Mexico after a long ...

The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into ...

Atalanta Therapeutics is pioneering RNA interference (RNAi) for the treatment of neurological diseases, having developed a proprietary platform that, for the first time enables RNAi to be deployed ...

Virgin River fans were left baffled by Lizzie and Denny's decision to not test their baby for Huntington's disease in season six of the Netflix drama ...